These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The effect of various cytostatic drugs on the growth of 12 chosen mycobacterial strains]. Schwartz E Prax Pneumol; 1971 May; 25(5):278-86. PubMed ID: 5556356 [No Abstract] [Full Text] [Related]
6. Attempt to establish a correlation between the alkylation ability and antitumor activity of some bis(2-chloroethyl)aminoethyl esters of carboxylic acids. Manolov I; Golovinsky EV Pharmazie; 1988 Mar; 43(3):218-9. PubMed ID: 3380873 [No Abstract] [Full Text] [Related]
7. Biochemical approaches to new cancer chemotherapeutic agents. Heidelberger C Proc Natl Cancer Conf; 1970; 6():599-604. PubMed ID: 5458123 [No Abstract] [Full Text] [Related]
8. [New ways of the chemotherapy of cancer]. Schmidt CG Krebsarzt; 1969; 24(3):129-49. PubMed ID: 5809854 [No Abstract] [Full Text] [Related]
9. [Interaction between drugs and macromolecules]. Simard R Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):249-56. PubMed ID: 5148884 [No Abstract] [Full Text] [Related]
10. Synthesis, chemistry, and preliminary pharmacology of arsenical nitrogen mustards and structurally related nonalkylating arsenicals. Bardos TJ; Datta-Gupta N; Hebborn P J Med Chem; 1966 Mar; 9(2):221-7. PubMed ID: 5911802 [No Abstract] [Full Text] [Related]
11. Effects of a new bifunctional alkylating agent (PTT-119) on in vitro growth of human cell lines and normal myeloid progenitors (CFU-GM). Lemoli RM; Visani G; Tosi P; Mazza P; Motta MR; Rizzi S; Zinzani PL; Poluzzi C; Gherlinzoni F; Tura S Haematologica; 1988; 73(3):195-200. PubMed ID: 3139515 [No Abstract] [Full Text] [Related]
12. The contribution of alkylation to the activity of quinone antitumor agents. Begleiter A Can J Physiol Pharmacol; 1986 May; 64(5):581-5. PubMed ID: 3730943 [TBL] [Abstract][Full Text] [Related]
13. Trends in searching for antitumor compounds. Preobrazhenskaya MN Natl Cancer Inst Monogr; 1977 Mar; (45):195-205. PubMed ID: 337151 [No Abstract] [Full Text] [Related]
14. Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy--a review. Waxman DJ Cancer Res; 1990 Oct; 50(20):6449-54. PubMed ID: 2208103 [No Abstract] [Full Text] [Related]
15. Alkylating agents. Connors TA Cancer Chemother Biol Response Modif; 1990; 11():29-44. PubMed ID: 2223396 [No Abstract] [Full Text] [Related]
16. Alkylating agents. Connors TA Cancer Chemother Biol Response Modif; 1992; 13():31-44. PubMed ID: 1389913 [No Abstract] [Full Text] [Related]
17. Modulation of alkylating agents by lonidamine in vivo. Teicher BA; Holden SA; Herman TS; Frei E Semin Oncol; 1991 Apr; 18(2 Suppl 4):7-10. PubMed ID: 1903216 [TBL] [Abstract][Full Text] [Related]
18. Alkylating agents. Berger NA Cancer Chemother Biol Response Modif; 1994; 15():32-43. PubMed ID: 7779588 [No Abstract] [Full Text] [Related]
19. Preclinical studies and clinical correlation of the effect of alkylating dose. Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059 [TBL] [Abstract][Full Text] [Related]
20. [Membrane mechanisms of the effect of alkylating cytostatic agents]. Mukhin VV; Poda GI; Luĭk AI; Baldenkov GN Biull Eksp Biol Med; 1990 Apr; 109(4):351-3. PubMed ID: 2386826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]